Request Demo
Last update 27 Sep 2025
Sacubitril/Allisartan Isoproxil/Amlodipine Besylate
Last update 27 Sep 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms S086/苯磺酸氨氯地平, SAL 0130, SAL-0130 + [1] |
Action antagonists, inhibitors |
Mechanism Angiotensin II receptor antagonists, calcium channel inhibitors(Calcium Channel inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with Sacubitril/Allisartan Isoproxil/Amlodipine BesylateCTR20253565
沙库巴曲阿利沙坦氨氯地平片与沙库巴曲阿利沙坦钙片联合苯磺酸氨氯地平片的生物等效性研究
[Translation] Bioequivalence study of sacubitril/alisartan/amlodipine tablets and sacubitril/alisartan calcium tablets combined with amlodipine besylate tablets
100 Clinical Results associated with Sacubitril/Allisartan Isoproxil/Amlodipine Besylate
Login to view more data
100 Translational Medicine associated with Sacubitril/Allisartan Isoproxil/Amlodipine Besylate
Login to view more data
100 Patents (Medical) associated with Sacubitril/Allisartan Isoproxil/Amlodipine Besylate
Login to view more data
100 Deals associated with Sacubitril/Allisartan Isoproxil/Amlodipine Besylate
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hypertension | Phase 3 | - | - | |
| Essential Hypertension | Phase 1 | China | 08 Sep 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free